查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2111511

骨科生技藥品市場：依產品類型、應用、最終用戶、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Orthobiologics Market, By Product Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 369 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025年生物性骨材市場價值為71.803億美元，預計從2026年到2033年將以10.9%的複合年成長率成長。

骨科生技藥品是一種利用生物來源材料治療各種肌肉骨骼疾病的天然療法。骨科生技藥品已被用於整形外科治療，以增強骨骼、軟骨、肌腱和生技藥品的再生和修復能力。它們旨在促進康復，並改善脊椎融合手術、骨折修復和重組等外科手術後的狀況。

骨科生物材料種類繁多，包括黏彈性移植物、骨生長因子、去礦骨基質、合成骨移植物和細胞同種異體移植物。黏彈性移植物是一種凝膠製劑，注射到關節中可緩解關節疼痛並改善關節活動度，可用於治療關節炎。這些注射劑應用於多個領域，包括脊椎融合手術、顎顏面和牙科手術以及軟組織增容和重組。總之，生物製藥在外科治療中對組織再生和疼痛緩解起著至關重要的作用。

骨科生物製劑市場 - 市場動態

交通事故和運動傷害的增加正在推高市場需求。

交通事故和運動傷害的增加是骨科生物製劑市場成長的主要驅動力，因為用於骨骼和組織修復的創新產品正在被廣泛應用。骨科生物製劑的應用能夠加速復健進程，進而改善骨折、關節損傷和運動傷害的治療效果，並有助於提升患者的活動能力和功能。例如，根據澳洲衛生與公共服務研究所（AIHS）的數據，截至2026年6月，約有1920萬（85%）15歲及以上的澳洲人參與運動或身體活動，其中7200人（12%）在騎自行車時遭受運動傷害。足球運動造成的運動傷害佔這些傷害的18%（1,0900例），而高風險因子正在推動骨科生物製劑市場的擴張，以應對這些問題。因此，高損傷風險正在推動對骨科生物製劑解決方案的需求。

骨科生物製劑市場－市場區隔分析：

全球骨科生技藥品市場按產品類型、應用、最終用戶和地區進行細分。

脫鈣骨基質（DBM）產品在生物製藥市場佔有重要佔有率。這主要是因為DBM產品具有骨傳導性和骨誘導性，使其廣泛應用於骨移植和整形外科手術，並有助於骨再生和癒合。例如，美國重症醫學會（ACS）於2025年10月進行的一項研究，利用微型CT和組織學分析，在骨缺損模型中測試了含有骨髓間質幹細胞（BMSCs）的3D微孔DBM。術後4週和8週，骨形成率均有提升。這種多孔交聯的DBM具有較大的表面積，有利於BMSCs的黏附和增殖，並釋放TGF-BETA、FGF、BMP和IGF等骨誘導因子。因此，DBM產品透過促進細胞黏附和成骨細胞增殖，促進了體外骨生長。

骨科生物製藥市場－區域分析

北美憑藉其先進的技術發展和完善的醫療基礎設施，在血管造影術導管市場佔有舉足輕重的地位。此外，該地區有利的報銷政策和法律規範也為市場成長提供了支持。例如，美國醫療保險支付諮詢委員會（Gov）提案，將2026年醫生和其他醫療保健專業服務的報銷率在2027年提高0.5個百分點，高於現行法律規定的2026年報銷率。這將使採用替代支付模式（A-APM）的醫生和其他醫療保健專業的整體報銷率提高到1.25%，其他醫療保健專業的報銷率提高到0.75%。這些有利的報銷政策預計將進一步加速北美市場的成長。

目錄

第1章：骨科生技藥品市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：骨科生技藥品的主要市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：骨科生技藥品產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章 骨科生技藥品市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：骨科生技藥品市場趨勢

  • 2025年骨科生技藥品市場佔有率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 骨科生技藥品市場：依產品類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按產品類型
    • 去礦物質骨基質（DBM）
    • 同種異體移植
    • 骨形成蛋白（BMPs）
    • 合成骨科生技藥品
    • 關節內粘稠補充療法產品
    • 富血小板血漿（PRP）
    • 骨髓抽吸物濃縮液（BMAC）
    • 其他

第8章 骨科生技藥品市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 脊椎固定
    • 創傷修復
    • 重組手術
    • 運動醫學
    • 顎顏面和牙科護理
    • 關節重組
    • 其他

第9章 骨科生技藥品市場：依最終使用者分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 醫院
    • 整形外科診所
    • 門診手術中心（ASC）
    • 其他

第10章 骨科生技藥品市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章：主要供應商分析：骨科生技藥品產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Medtronic plc
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • DePuy Synthes（Johnson & Johnson）
    • Smith+Nephew plc
    • Orthofix Medical Inc.
    • Globus Medical, Inc.
    • SeaSpine Holdings Corporation
    • Bioventus LLC
    • Anika Therapeutics, Inc.
    • Arthrex, Inc.
    • Bone Biologics Corporation
    • RTI Surgical Holdings, Inc.
    • MTF Biologics
    • LifeNet Health
    • Baxter International Inc.
    • Vericel Corporation
    • AlloSource
    • Others

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7232

OrthobiologicsMarket size was valued at US$ 7,180.3 Million in 2025, expanding at a CAGR of 10.9% from 2026 to 2033.

Orthobiologics are natural therapies that involve the use of biological materials from the body in treating various musculoskeletal diseases. Orthobiologics have been employed in the treatment of bones, cartilages, tendons, and ligaments in orthopedic treatments in order to enhance their capability of regeneration and repair. Orthobiologics seek to promote the process of accelerated recovery and improvement in surgical operations such as spinal fusion, fractures, and reconstruction.

There are various kinds of orthobiologic materials, which include viscosupplements, bone growth factors, demineralized bone matrix, synthetic bone grafts, and cellular allografts, among others. Viscosupplements are gel preparations that are injected into the joints in order to relieve joint pains and improve their flexibility; this helps in the treatment of arthritis. The injections can be applied in various fields, including spine fusion, maxillofacial and dental, and soft tissue augmentation and reconstruction. In conclusion, orthobiologics play an important role in regeneration and pain relief in surgical treatments.

Orthobiologics Market- Market Dynamics

Increasing Road Accidents and Sports Injuries to Boost Market Demand

Increasing road accidents and sports injuries are the key factors that drive growth in the market for orthobiologics because of the usage of innovative products for repairing the bones and tissues. Application of orthobiologics has helped in speeding up the recovery process and providing better results in the case of treating fractures, joint injuries, and sports injuries and improving mobility and functionality. For instance, in June 2026, according to the Australian Institute of Health and Welfare (Gov), around 19.2 million Australians aged 15 years and above (85%) had participated in sports activities and physical activity, out of which 12% of participants, or 7200 cases, had sustained sports injuries while riding bicycles. Where football accounts for 18% of sports injuries (10,900 cases), the risk factor is high, thus spurring the Orthobiologics market in order to resolve these issues. Thus, there is a high risk of injuries, thereby fueling the demand for orthobiologic solutions.

Orthobiologics Market- Segmentation Analysis:

The Global Orthobiologics market is segmented on the basis of Product Type, Application, End User, and Region.

Demineralized Bone Matrix (DBM) products hold a significant share in the orthobiologics market. This is mainly due to the fact that the DBM products are widely used in bone grafting and orthopedic surgery because of their osteoconductive and osteoinductive characteristics and thus help in the process of regeneration and healing of the bone. For example, in October 2025, according to the study conducted by ACS (Org.), three-dimensional microporous DBM with BMSCs was tested in a bone defect model using micro-CT and histology analysis. There was a rise in the bone formation rates at 4 weeks and 8 weeks post-operation. The porous and cross-linked DBM had more surface for adhesion and proliferation of BMSCs and released osteoinductive factors such as TGF-B, FGFs, BMPs, and IGFs. Thus, DBM products helped in bone growth in vitro by facilitating cell attachments and growth of osteogenic cells.

Orthobiologics Market- Geographical Insights

North America held a notable position in the angiographic catheter market due to the existence of technology development and well-developed healthcare infrastructure. In addition, the region is supported by favorable reimbursement policies and regulatory frameworks that promote the growth of the market. For example, according to the U.S. Medicare Payment Advisory Commission (Gov), in 2026, the payment rates for physician and other health professional services were proposed to increase in 2027 by 0.5 percentage points above the rate set by the current law in 2026. This resulted in an overall increase in the payment rate for physicians and other health professionals practicing in A-APMs to 1.25% and others to 0.75%. These favorable reimbursement policies are expected to further strengthen market growth across North America.

Orthobiologics Market- Competitive Landscape:

The Orthobiologics market includes key players such as Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings, Inc., DePuy Synthes (Johnson & Johnson), and Smith+Nephew plc. These firms are working on product innovations in order to increase their market share and adapt to the changing demands of orthopedic procedures. In May 2026, DePuy Synthes signed an exclusive distribution deal with CGBIO for NOVOSIS, which is used as a bone graft substitute for the treatment of spine, craniomaxillofacial, and trauma disorders. Such developments are expected to bring innovations in the orthobiologics market.

Recent Developments:

In March 2026, Vericel Corporation got FDA approval for the manufacture of MACI(R) in its new advanced therapy manufacturing facility, which greatly raised the production capacity of its cartilage restoration treatment.

In January 2025, LifeNet Health introduced PliaFX(R) Flo, a new-generation demineralized bone matrix with fiber that is available in a prefilled syringe for better handling and applications in spinal surgery and orthopedic treatments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ORTHOBIOLOGICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • DePuy Synthes (Johnson & Johnson)
  • Smith+Nephew plc
  • Orthofix Medical Inc.
  • Globus Medical, Inc.
  • SeaSpine Holdings Corporation
  • Bioventus LLC
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • Bone Biologics Corporation
  • RTI Surgical Holdings, Inc.
  • MTF Biologics
  • LifeNet Health
  • Baxter International Inc.
  • Vericel Corporation
  • AlloSource
  • Others

GLOBALORTHOBIOLOGICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Demineralized Bone Matrix (DBM)
  • Allografts
  • Bone Morphogenetic Proteins (BMPs)
  • Synthetic Orthobiologics
  • Viscosupplementation Products
  • Platelet-Rich Plasma (PRP)
  • Bone Marrow Aspirate Concentrate (BMAC)
  • Others

GLOBAL ORTHOBIOLOGICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Spinal Fusion
  • Trauma Repair
  • Reconstructive Surgery
  • Sports Medicine
  • Maxillofacial & Dental
  • Joint Reconstruction
  • Others

GLOBAL ORTHOBIOLOGICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others

GLOBAL ORTHOBIOLOGICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Orthobiologics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
  • 2.2. Competitive Insights

3. Orthobiologics Key Market Trends

  • 3.1. Orthobiologics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Orthobiologics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Orthobiologics Market Opportunities
  • 3.4. Orthobiologics Market Future Trends

4. Orthobiologics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Orthobiologics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Orthobiologics Market Landscape

  • 6.1. Orthobiologics Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Orthobiologics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
    • 7.1.2. Demineralized Bone Matrix (DBM)
    • 7.1.3. Allografts
    • 7.1.4. Bone Morphogenetic Proteins (BMPs)
    • 7.1.5. Synthetic Orthobiologics
    • 7.1.6. Viscosupplementation Products
    • 7.1.7. Platelet-Rich Plasma (PRP)
    • 7.1.8. Bone Marrow Aspirate Concentrate (BMAC)
    • 7.1.9. Others

8. Orthobiologics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Spinal Fusion
    • 8.1.3. Trauma Repair
    • 8.1.4. Reconstructive Surgery
    • 8.1.5. Sports Medicine
    • 8.1.6. Maxillofacial & Dental
    • 8.1.7. Joint Reconstruction
    • 8.1.8. Others

9. Orthobiologics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Orthopedic Clinics
    • 9.1.4. Ambulatory Surgical Centers (ASCs)
    • 9.1.5. Others

10. Orthobiologics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Orthobiologics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Orthobiologics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Orthobiologics Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Orthobiologics Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Orthobiologics Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Orthobiologics Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Medtronic plc
    • 11.2.2. Stryker Corporation
    • 11.2.3. Zimmer Biomet Holdings, Inc.
    • 11.2.4. DePuy Synthes (Johnson & Johnson)
    • 11.2.5. Smith+Nephew plc
    • 11.2.6. Orthofix Medical Inc.
    • 11.2.7. Globus Medical, Inc.
    • 11.2.8. SeaSpine Holdings Corporation
    • 11.2.9. Bioventus LLC
    • 11.2.10. Anika Therapeutics, Inc.
    • 11.2.11. Arthrex, Inc.
    • 11.2.12. Bone Biologics Corporation
    • 11.2.13. RTI Surgical Holdings, Inc.
    • 11.2.14. MTF Biologics
    • 11.2.15. LifeNet Health
    • 11.2.16. Baxter International Inc.
    • 11.2.17. Vericel Corporation
    • 11.2.18. AlloSource
    • 11.2.19. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us